Literature DB >> 22345340

Evidence for liver injury in the setting of obstructive sleep apnea.

Thomas J Byrne1, James M Parish, Virend Somers, Bashar A Aqel, Jorge Rakela.   

Abstract

INTRODUCTION: Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are both strongly associated with obesity. Whether OSA is an independent risk factor for liver injury is uncertain.
OBJECTIVE: To assess the hypothesis that OSA is associated with liver injury independent of obesity.
MATERIALS AND METHODS: We reviewed the histories of 73 consecutive patients referred to a hospital-based sleep lab because of suspected OSA. OSA was determined to be present if the apnea-hypopnea index was > 10. Obesity was defined as a BMI ≥ 30 kg/m 2 . Patients were included for analysis if they had aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels obtained within 60 days of sleep study. Patients with evidence of viral hepatitis, autoimmune-, metabolic- or established alcoholic-liver disease were excluded. Patients who reported alcohol intake equivalent to a dose ≥ 20 g/day were also excluded. 53 of 73 patients met study criteria. Patients were subdivided for analysis into groups meeting or not meeting OSA and obesity criteria, and having or not having elevated aminotransferase levels.
RESULTS: 35/53 patients (66%) had OSA. 31/53 (58%) patients were obese. 15 (28%) and 12 (23%) patients had elevated AST and ALT, respectively. Mean age, gender distribution, mean BMI and percentage with either diabetes or hyperlipidemia were not significantly different in those with or without OSA. Elevated ALT was found in 11/35 (31%) patients with OSA, compared to 1/18 patients without OSA (p = 0.041). Frequency of elevated AST [obese 11/31 (35%); non-obese 4/22 (18%)] or ALT [obese 10/31 (32%); non-obese 2/22 (9%)] was not significantly different in the obese and non-obese cohorts.
CONCLUSIONS: OSA may be a risk factor for liver injury independent of obesity. The prevalence and nature of liver disease in the setting of OSA should be determined with larger, prospective studies. The impact of OSA treatment, if any, on liver injury should be similarly evaluated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345340

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  9 in total

1.  Evaluation of Liver Functions Based on Serum Aminotransferase Enzyme Levels in Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Doğan Atan; Sabri Köseoğlu; Kürşat Murat Özcan; Aykut İkincioğulları; Ayşe Betül Topak; İbrahim Özcan; Hüseyin Dere
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-09-22

2.  Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.

Authors:  Kathleen E Corey; Joseph Misdraji; Lou Gelrud; Lindsay Y King; Hui Zheng; Atul Malhotra; Raymond T Chung
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

3.  Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

4.  4-phenylbutyric acid attenuates endoplasmic reticulum stress-mediated apoptosis and protects the hepatocytes from intermittent hypoxia-induced injury.

Authors:  Liu Xin; Wu Fan; Du Tingting; Sun Zuoming; Zhang Qiang
Journal:  Sleep Breath       Date:  2018-10-15       Impact factor: 2.816

5.  Association of Sleep Disorders with Nonalcoholic Fatty Liver Disease (NAFLD): A Population-based Study.

Authors:  Heshaam M Mir; Maria Stepanova; Hena Afendy; Rebecca Cable; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2013-07-02

6.  Perspectives in obesity and pregnancy.

Authors:  Federico G Mariona
Journal:  Womens Health (Lond)       Date:  2017-02-10

7.  The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis.

Authors:  Anas Renno; Yousef Abdel-Aziz; Yaseen Alastal; Sadik Khuder; Syed Hasan; Ragheb Assaly; Ali Nawras
Journal:  Clin Exp Hepatol       Date:  2021-03-25

8.  Prevalence and determinants of metabolic syndrome: a cross-sectional survey of general medical outpatient clinics using National Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana.

Authors:  Bernard Omech; Jose-Gaby Tshikuka; Julius C Mwita; Billy Tsima; Oathokwa Nkomazana; Kennedy Amone-P'Olak
Journal:  Diabetes Metab Syndr Obes       Date:  2016-08-30       Impact factor: 3.168

9.  Elevated Serum Liver Enzymes in Patients with Obstructive Sleep Apnea-hypopnea Syndrome.

Authors:  Jie Li; Yan-Lin Zhang; Rui Chen; Yi Wang; Kang-Ping Xiong; Jun-Ying Huang; Fei Han; Chun-Feng Liu
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.